• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.69% Nasdaq Up 0.44%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    115.71 Up 2.64(2.33%) 4:00PM EDT
    |After Hours : 115.60 Down 0.11 (0.10%) 7:59PM EDT
    Add to Portfolio
    Prev Close:113.07
    Open:118.40
    Bid:115.51 x 200
    Ask:115.60 x 200
    1y Target Est:124.47
    Beta:0.88
    Earnings Date:Oct 26 - Oct 30 (Est.)
    Day's Range:115.11 - 119.46
    52wk Range:85.95 - 123.37
    Volume:23,144,762
    Avg Vol (3m):10,968,300
    Market Cap:170.05B
    P/E (ttm):13.19
    EPS (ttm):8.77
    Div & Yield:1.72 (1.50%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    GILDUp 2.33%170.05B
    GSKUp 2.18%102.93B
    PFEUp 1.16%220.20B
    RHHBYUp 0.05%245.78B

    Key Statistics

    Forward P/E (1 yr):10.39
    P/S (ttm):6.05
    Ex-Dividend Date:12-Jun-15

    Analysts

    Annual EPS Est (Dec-15) :10.87
    Quarterly EPS Est (Sep-15) :2.64
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):0.50

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback